Evidence map›Paper›PMID 36008183›Full record

ArticleGynecologic oncology2022

Cardiovascular disease diagnoses among older women with endometrial cancer.

Chelsea Anderson, Andrew F Olshan, Victoria L Bae-Jump, Wendy R Brewster, Jennifer L Lund, Hazel B Nichols

Abstract read
In one paragraph

Article in Gynecologic oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The intersection of heart failure and cancer in women: a review.Frontiers in cardiovascular medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chelsea AndersonDepartment of Epidemiology, University of North Carolina, Chapel Hill, NC, USA. Electronic address: cea39@email.unc.edu.
Andrew F OlshanDepartment of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
Victoria L Bae-JumpDepartment of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC, USA.
Wendy R BrewsterDepartment of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, NC, USA.
Jennifer L LundDepartment of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
Hazel B NicholsDepartment of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
University of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
NCI NIH HHS P30 CA016086
6 · The paper itself

Abstract

backgroundEndometrial cancer (EC) shares risk factors (e.g. obesity) with cardiovascular disease (CVD), yet little research has investigated CVD diagnoses among EC survivors. We aimed to describe the burden of CVD diagnoses among older women with EC compared to women without a cancer history.

methodsWomen aged 66+ years with an EC diagnosis during 2004-2017 (N = 44,386) and matched women without cancer (N = 221,219) were identified in the SEER-Medicare linked data. An index date was defined as the cancer diagnosis date of the EC case in that matched set. ICD-9/10 diagnosis codes were used to define CVD outcomes in the Medicare claims. Prevalent CVD was identified using diagnosis codes in the year before the index date. Hazard ratios (HRs) for incident CVD diagnoses after the index date were estimated using multivariable Cox proportional hazards regression. Women with a prevalent CVD were excluded from incidence analyses for that outcome.

resultsCompared to women without cancer, women with EC had a higher prevalence of CVD diagnoses at the index date. In analyses beginning follow-up at 1 year post-index date, EC survivors had an increased risk of incident CVD diagnoses including ischemic heart diseases (HR = 1.73; 95% CI: 1.69-1.78), pulmonary heart disease (HR = 1.95; 95% CI: 1.88-2.02), and diseases of the veins and lymphatics (HR = 2.71; 95% CI: 95% CI: 2.64-2.78). Risk of CVD diagnoses among women with EC was also elevated within the first year post-index date.

conclusionsManagement of pre-existing CVD and monitoring for incident CVD may be critical during EC treatment and throughout long-term survivorship.

Indexed as

Cardiovascular DiseasesEndometrial NeoplasmsAgedFemaleHumansIncidenceMedicareProportional Hazards ModelsRisk FactorsUnited States

Identifiers

PMID36008183
PMCPMC13307059
OpenAlexW4292980126

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.